Embase

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article may contain excessive or inappropriate references to self-published sources. Please help improve it by removing references to unreliable sources where they are used inappropriately. (August 2011) (Learn how and when to remove this message) This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Embase" – news · newspapers · books · scholar · JSTOR (August 2011) (Learn how and when to remove this message) (Learn how and when to remove this message)

Embase (often styled EMBASE for Excerpta Medica dataBASE) is a biomedical and pharmacological bibliographic database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug. Embase, produced by Elsevier, contains over 32 million records from over 8,500 currently published journals from 1947^[1] to the present. Through its international coverage, daily updates, and drug indexing with EMTREE, Embase enables tracking and retrieval of drug information in the published literature. Each record is fully indexed and Articles in Press are available for some records and In Process are available for all records, ahead of full indexing. Embase's international coverage expands across biomedical journals from 95 countries and is available through a number of database vendors.^[2]